Company Overview and News


Add NVTA
to your dashboard

Headline News

2 Small Biotechs To Buy Now

2018-01-17 seekingalpha
Some small biotech stocks have had a rough go of it recently including yesterday as the sector had a severe intra-day reversal. (113-2)

BRIEF-Invitae More Than Doubles Annual Volume, Exceeds Full-Year 2017 Guidance, Projects Momentum To Continue In 2018

2018-01-08 reuters
* INVITAE MORE THAN DOUBLES ANNUAL VOLUME, EXCEEDS FULL-YEAR 2017 GUIDANCE, AND PROJECTS MOMENTUM TO CONTINUE IN 2018 (18-0)

Invitae - The Next Generation Of Medicine Is Genomics

2018-01-06 seekingalpha
Founder and Executive Chairman ran Genomic Health from a start-up into a public company worth $1 billion. (22-0)

NVTA / Invitae Corp. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-12-01 fintel.io
Invitae Corp. (NYSE:NVTA) has 95 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,726,761 shares. Largest shareholders include Baker Brothers Advisors LP, Wellington Management Group Llp, Park West Asset Management LLC, Camber Capital Management LLC, BlackRock Inc., Redmile Group, LLC, Perceptive Advisors Llc, Millennium Management Llc, Vanguard Group Inc, and Orbimed Advisors Llc. (50-0)

Reimbursement cuts on lab tests pressure US lab firm shares - Channel NewsAsia

2017-11-20 channelnewsasia
REUTERS: A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as US$3 billion over five years, but hurt margins of U.S. laboratory companies. (34-1)

Reimbursement cuts on lab tests pressure US lab firm shares

2017-11-20 reuters
(Reuters) - A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies. (34-2)

Large Opportunity For Smaller Arbitrageurs

2017-11-13 seekingalpha
The deal is very small with a total value of roughly $33MM, which will lead to very little institutional attention. (20-3)

BRIEF-Combimatrix Corp stockholders approve merger agreement with Invitae Corp

2017-11-10 reuters
* Combimatrix Corp says ‍approximately 1.79 million of common shares voting in meeting voted in favor of approval & adoption of all-stock merger agreement​ Source text for Eikon: Further company coverage: (20-0)

Biotech Forum Daily Digest: Redhill's Bungled Secondary

2017-11-09 seekingalpha
The biotech sector continues to head down this week as sentiment on the high beta areas of the market weaken. (159-1)

Invitae 2017 Q3 - Results - Earnings Call Slides

2017-11-07 seekingalpha
The following slide deck was published by Invitae in conjunction with their 2017 Q3 earnings call. (18-0)

Invitae's (NVTA) CEO Sean George on Q3 2017 Results - Earnings Call Transcript

2017-11-07 seekingalpha
Good afternoon. My name is Chris and I will be your conference operator today. At this time, I would like to welcome everyone to the Invitae's Third Quarter 2017 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. (18-0)

Invitae Corp to Host Earnings Call

2017-11-06 accesswire
(18-0)

Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide

2017-10-05 prnewswire
Refinements to existing guidelines establish a more detailed and transparent approach for classifying variants at scale (18-0)

Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman

2017-10-03 prnewswire
Atlas Genetics Ltd., the ultra-rapid, point-of-care (POC) testing company for women's and family health, today announced that Jeffrey R. Luber has been appointed Chief Executive Officer effective 1 October 2017. Dr John Clarkson, current founding CEO, will become Executive Chairman and current chairman, Neil Butler, will remain with the Company as a non-executive director of the Board. (34-1)

BRIEF-CombiMatrix Corp says co's unit entered into Marketing and Laboratory Services Agreement with Invitae Corp and its unit

2017-09-27 reuters
* CombiMatrix Corp - ‍on Sept 25, co’s unit CombiMatrix Molecular Diagnostics Inc entered into marketing and laboratory services agreement with Invitae Corp and its unit (20-0)

CUSIP: 46185L103